Short interest in Actuate Therapeutics Inc (NASDAQ:ACTU) increased during the last reporting period, rising from 20.25K to 33.46K. This put -% of the company's publicly available shares short.

Short interest for Actuate Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Actuate Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 61.43K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.